Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D)

被引:153
作者
Vasen, H. F. A. [1 ,2 ]
Ghorbanoghli, Z. [2 ]
Bourdeaut, F. [3 ]
Cabaret, O. [4 ]
Caron, O. [5 ]
Duval, A. [6 ]
Entz-Werle, N. [7 ]
Goldberg, Y. [8 ]
Ilencikova, D. [9 ]
Kratz, C. P. [10 ]
Lavoine, N. [11 ]
Loeffen, J. [12 ]
Menko, F. H. [13 ]
Muleris, M. [6 ]
Sebille, G. [14 ]
Colas, C. [15 ]
Burkhardt, B. [16 ]
Brugieres, L. [11 ]
Wimmer, K. [17 ]
机构
[1] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 AA Leiden, Netherlands
[2] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands
[3] Inst Curie, Dept Pediat Oncol, Paris, France
[4] Gustave Roussy Canc Inst, Dept Genet, Villejuif, France
[5] Gustave Roussy Canc Inst, Dept Oncogenet, Villejuif, France
[6] Saint Antoine Hosp, INSERM, Team Microsatellite Instabil & Canc, UMRS 938, Paris, France
[7] Univ Hosp, Dept Pediat Oncol, Strasbourg, France
[8] Hadassah Hebrew Med Ctr, Dept Oncol, Sharret Inst, Jerusalem, Israel
[9] Comenius Univ, Sch Med, Univ Childrens Hosp, Dept Pediat, Bratislava, Slovakia
[10] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany
[11] Gustave Roussy Canc Inst, Dept Pediat, Villejuif, France
[12] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Hematol & Oncol, Nijmegen, Netherlands
[13] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands
[14] Gustave Roussy Canc Inst, Dept Dermatol, Villejuif, France
[15] Hop La Pitie Salpetriere, APHP, Dept Genet, Paris, France
[16] Univ Hosp, Dept Pediat Hematol & Oncol, Munster, Germany
[17] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria
关键词
CMMR-D; Constitutional mismatch repair deficiency; Surveillance; Guidelines; Tumour spectrum; BIALLELIC MSH6 MUTATIONS; COLORECTAL-CANCER CELLS; NON-HODGKIN-LYMPHOMA; LYNCH SYNDROME; COLON-CANCER; MICROSATELLITE-INSTABILITY; NEUROFIBROMATOSIS TYPE-1; CORPUS-CALLOSUM; GENE-MUTATIONS; RECTAL-CANCER;
D O I
10.1136/jmedgenet-2013-102238
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome (LS) is an autosomal dominant disorder caused by a defect in one of the DNA mismatch repair genes: MLH1, MSH2, MSH6 and PMS2. In the last 15years, an increasing number of patients have been described with biallelic mismatch repair gene mutations causing a syndrome referred to as constitutional mismatch repair-deficiency' (CMMR-D). The spectrum of cancers observed in this syndrome differs from that found in LS, as about half develop brain tumours, around half develop digestive tract cancers and a third develop haematological malignancies. Brain tumours and haematological malignancies are mainly diagnosed in the first decade of life, and colorectal cancer (CRC) and small bowel cancer in the second and third decades of life. Surveillance for CRC in patients with LS is very effective. Therefore, an important question is whether surveillance for the most common CMMR-D-associated cancers will also be effective. Recently, a new European consortium was established with the aim of improving care for patients with CMMR-D. At a workshop of this group held in Paris in June 2013, one of the issues addressed was the development of surveillance guidelines. In 1968, criteria were proposed by WHO that should be met prior to the implementation of screening programmes. These criteria were used to assess surveillance in CMMR-D. The evaluation showed that surveillance for CRC is the only part of the programme that largely complies with the WHO criteria. The values of all other suggested screening protocols are unknown. In particular, it is questionable whether surveillance for haematological malignancies improves the already favourable outcome for patients with these tumours. Based on the available knowledge and the discussions at the workshop, the European consortium proposed a surveillance protocol. Prospective collection of all results of the surveillance is needed to evaluate the effectiveness of the programme.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 65 条
[1]   Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome [J].
Baas, Annette F. ;
Gabbett, Michael ;
Rimac, Milan ;
Kansikas, Minttu ;
Raphael, Martine ;
Nievelstein, Rutger A. J. ;
Nicholls, Wayne ;
Offerhaus, Johan ;
Bodmer, Danielle ;
Wernstedt, Annekatrin ;
Krabichler, Birgit ;
Strasser, Ulrich ;
Nystrom, Minna ;
Zschocke, Johannes ;
Robertson, Stephen P. ;
van Haelst, Mieke M. ;
Wimmer, Katharina .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (01) :55-61
[2]   The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms [J].
Borie, Claire ;
Colas, Chrystelle ;
Dartigues, Peggy ;
Lazure, Thierry ;
Rince, Patricia ;
Buhard, Olivier ;
Folliot, Patrick ;
Chalastanis, Alexandra ;
Muleris, Martine ;
Hamelin, Richard ;
Mercier, Dominique ;
Oliveira, Carla ;
Seruca, Raquel ;
Chadburn, Amy ;
Leblond, Veronique ;
Barete, Stephane ;
Gaidano, Gianluca ;
Martin, Antoine ;
Gaulard, Philippe ;
Flejoul, Jean-Francois ;
Raphael, Martine ;
Duval, Alex .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) :2360-2366
[3]   Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits [J].
Brasme, Jean-Francois ;
Morfouace, Michele ;
Grill, Jacques ;
Martinot, Alain ;
Amalberti, Rene ;
Bons-Letouzey, Catherine ;
Chalumeau, Martin .
LANCET ONCOLOGY, 2012, 13 (10) :E445-E459
[4]   The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence [J].
Burkhardt, B ;
Zimmermann, M ;
Oschlies, I ;
Niggli, F ;
Mann, G ;
Parwaresch, R ;
Riehm, H ;
Schrappe, M ;
Reiter, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (01) :39-49
[5]   Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment [J].
Cahill, Daniel P. ;
Levine, Kymberly K. ;
Betensky, Rebecca A. ;
Codd, Patrick J. ;
Romany, Candice A. ;
Reavie, Linsey B. ;
Batchelor, Tracy T. ;
Futreal, P. Andrew ;
Stratton, Michael R. ;
Curry, William T. ;
Iafrate, A. John ;
Louis, David N. .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2038-2045
[6]   Azathioprine-Induced Carcinogenesis in Mice According to Msh2 Genotype [J].
Chalastanis, Alexandra ;
Penard-Lacronique, Virginie ;
Svrcek, Magali ;
Defaweux, Valerie ;
Antoine, Nadine ;
Buhard, Olivier ;
Dumont, Sylvie ;
Fabiani, Bettina ;
Renault, Isabelle ;
Tubacher, Emmanuel ;
Flejou, Jean-Francois ;
Riele, Hein Te ;
Duval, Alex ;
Muleris, Martine .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (22) :1731-1740
[7]  
Charara M, 2004, ANTICANCER RES, V24, P3161
[8]  
Des Guetz G, 2007, ANTICANCER RES, V27, P2715
[9]   Chemotherapy of MMR-deficient colorectal cancer [J].
Devaud, N. ;
Gallinger, S. .
FAMILIAL CANCER, 2013, 12 (02) :301-306
[10]   Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis [J].
Dorard, Coralie ;
de Thonel, Aurelie ;
Collura, Ada ;
Marisa, Laetitia ;
Svrcek, Magali ;
Lagrange, Anais ;
Jego, Gaetan ;
Wanherdrick, Kristell ;
Joly, Anne Laure ;
Buhard, Olivier ;
Gobbo, Jessica ;
Penard-Lacronique, Virginie ;
Zouali, Habib ;
Tubacher, Emmanuel ;
Kirzin, Sylvain ;
Selves, Janick ;
Milano, Gerard ;
Etienne-Grimaldi, Marie-Christine ;
Bengrine-Lefevre, Leila ;
Louvet, Christophe ;
Tournigand, Christophe ;
Lefevre, Jeremie H. ;
Parc, Yann ;
Tiret, Emmanuel ;
Flejou, Jean-Francois ;
Gaub, Marie-Pierre ;
Garrido, Carmen ;
Duval, Alex .
NATURE MEDICINE, 2011, 17 (10) :1283-U316